Tumours of the Biliary Tract
Tumours of the Biliary Tract
Overview
Benign=rare. Malignant: gallbladder carcinoma, ampulla of Vater/extrahepatic bile duct carcinoma.
Benign tumours
Exceedingly rare: papilloma, adenoma, ADENOMYOMA(commonest), fibroma, lipoma, myxoma, haemangioma. Resemble counterparts elsewhere.
Carcinoma of gallbladder
MOST PREVALENT extrahepatic biliary tract cancer. Women 4:1(like cholelithiasis/cholecystitis pattern), peak 7th decade. Often undetected until inoperable.
Etiology:
- Cholelithiasis+cholecystitis — MOST significant association, causality UNPROVEN. Present in 75% of gallbladder CA, but only 0.5% of stone patients get cancer (association ≠ elevated absolute risk — key stats point). PORCELAIN GALLBLADDER = genuinely elevated risk (exception)
- Chemical carcinogens — methylcholanthrene, nitrosamines, pesticides. ↑rubber industry workers
- Genetic — regional clustering. ↑Japanese immigrants, SW Native Americans. ↓American Indians, Mexicans
- Misc — prior biliary surgery, IBD(UC+Crohn’s)
Morphology: commonest site=FUNDUS>neck. Gross: INFILTRATING(diffuse thickening/induration, ±deep ulceration into wall+liver bed, firm scirrhous) vs FUNGATING(friable papillary/cauliflower growth into lumen+wall+beyond).
Micro: ADENOCARCINOMA 90%(papillary/infiltrative, well-poor diff, mostly non-mucin, some colloid) > SCC ~5%(from squamous metaplasia) > adenosquamous(uncommon).
Clinical: slow-growing, LATE symptoms — often found incidentally during cholecystectomy. Symptomatic=pain, jaundice, mass, anorexia, weight loss — by then usually invaded liver+mets to nodes/lung/peritoneum/GI.
Ampullary/extrahepatic bile duct carcinoma
Ampullary carcinoma(pure) = adenocarcinoma at ampulla, often from pre-existing villous/tubulovillous ampullary adenoma. ADVANCED disease = indistinguishable from 3 neighbours (duodenal CA w/ secondary ampullary spread; terminal bile duct CA infiltrating ampulla; pancreatic head CA merging into ampulla) → umbrella term PERIAMPULLARY CARCINOMA (4 sites: ampulla, duodenum, terminal CBD, pancreatic head) — reflects genuine diagnostic limitation at advanced stage, not arbitrary grouping.
UNLIKE other biliary disease: MORE COMMON in MALES, peak 6th decade.
Etiology: pre-existing ampullary polyp, FAP, neurofibromatosis type 1. NO gallstone association (KEY CONTRAST with gallbladder cancer). Bile duct cancer specifically: UC, sclerosing cholangitis, parasitic infestation (Fasciola hepatica, Ascaris lumbricoides, Clonorchis sinensis).
Morphology: ampullary=intra-ampullary(bulges into duodenum) or periampullary(circumferential). Extrahepatic bile duct sites(↓frequency): ampulla of Vater>lower CBD>hepatic ducts>hepatic duct confluence. Gross: ampullary=papillary, projects into duodenal lumen. Bile duct=small(1-2cm), duct wall thickening. Micro: adenocarcinoma, well-poor diff, ±mucin. PERINEURAL INVASION frequent.
Clinical: OBSTRUCTIVE JAUNDICE(+intense pruritus)=usual presentation. ±pain, steatorrhoea, weight loss, weakness. Nodal mets. Prognosis BETTER than pancreatic cancer AND bile duct carcinoma.
Clinical relevance
Gallbladder CA’s association-without-causation with stones (75% of cancers have stones, but only 0.5% of stone patients get cancer) = classic stats point — high association one direction ≠ elevated absolute risk other direction — why stones alone don’t justify prophylactic cholecystectomy. Porcelain gallbladder = genuine elevated-risk EXCEPTION that tips risk-benefit toward cholecystectomy. Periampullary umbrella term = reflects genuine diagnostic limitation (4 cancers indistinguishable when advanced), not arbitrary. Gallstone-association split (present in gallbladder CA, ABSENT in bile duct/ampullary CA) = clearest etiologic discriminator despite anatomic proximity — ampullary/bile duct CA tracks with IBD/sclerosing cholangitis/parasites instead.
Tumours of the Biliary Tract
Overview
Benign=rare. Malignant: gallbladder carcinoma, ampulla of Vater/extrahepatic bile duct carcinoma.
Benign tumours
Exceedingly rare: papilloma, adenoma, ADENOMYOMA(commonest), fibroma, lipoma, myxoma, haemangioma. Resemble counterparts elsewhere.
Carcinoma of gallbladder
MOST PREVALENT extrahepatic biliary tract cancer. Women 4:1(like cholelithiasis/cholecystitis pattern), peak 7th decade. Often undetected until inoperable.
Etiology:
- Cholelithiasis+cholecystitis — MOST significant association, causality UNPROVEN. Present in 75% of gallbladder CA, but only 0.5% of stone patients get cancer (association ≠ elevated absolute risk — key stats point). PORCELAIN GALLBLADDER = genuinely elevated risk (exception)
- Chemical carcinogens — methylcholanthrene, nitrosamines, pesticides. ↑rubber industry workers
- Genetic — regional clustering. ↑Japanese immigrants, SW Native Americans. ↓American Indians, Mexicans
- Misc — prior biliary surgery, IBD(UC+Crohn’s)
Morphology: commonest site=FUNDUS>neck. Gross: INFILTRATING(diffuse thickening/induration, ±deep ulceration into wall+liver bed, firm scirrhous) vs FUNGATING(friable papillary/cauliflower growth into lumen+wall+beyond).
Micro: ADENOCARCINOMA 90%(papillary/infiltrative, well-poor diff, mostly non-mucin, some colloid) > SCC ~5%(from squamous metaplasia) > adenosquamous(uncommon).
Clinical: slow-growing, LATE symptoms — often found incidentally during cholecystectomy. Symptomatic=pain, jaundice, mass, anorexia, weight loss — by then usually invaded liver+mets to nodes/lung/peritoneum/GI.
Ampullary/extrahepatic bile duct carcinoma
Ampullary carcinoma(pure) = adenocarcinoma at ampulla, often from pre-existing villous/tubulovillous ampullary adenoma. ADVANCED disease = indistinguishable from 3 neighbours (duodenal CA w/ secondary ampullary spread; terminal bile duct CA infiltrating ampulla; pancreatic head CA merging into ampulla) → umbrella term PERIAMPULLARY CARCINOMA (4 sites: ampulla, duodenum, terminal CBD, pancreatic head) — reflects genuine diagnostic limitation at advanced stage, not arbitrary grouping.
UNLIKE other biliary disease: MORE COMMON in MALES, peak 6th decade.
Etiology: pre-existing ampullary polyp, FAP, neurofibromatosis type 1. NO gallstone association (KEY CONTRAST with gallbladder cancer). Bile duct cancer specifically: UC, sclerosing cholangitis, parasitic infestation (Fasciola hepatica, Ascaris lumbricoides, Clonorchis sinensis).
Morphology: ampullary=intra-ampullary(bulges into duodenum) or periampullary(circumferential). Extrahepatic bile duct sites(↓frequency): ampulla of Vater>lower CBD>hepatic ducts>hepatic duct confluence. Gross: ampullary=papillary, projects into duodenal lumen. Bile duct=small(1-2cm), duct wall thickening. Micro: adenocarcinoma, well-poor diff, ±mucin. PERINEURAL INVASION frequent.
Clinical: OBSTRUCTIVE JAUNDICE(+intense pruritus)=usual presentation. ±pain, steatorrhoea, weight loss, weakness. Nodal mets. Prognosis BETTER than pancreatic cancer AND bile duct carcinoma.
Clinical relevance
Gallbladder CA’s association-without-causation with stones (75% of cancers have stones, but only 0.5% of stone patients get cancer) = classic stats point — high association one direction ≠ elevated absolute risk other direction — why stones alone don’t justify prophylactic cholecystectomy. Porcelain gallbladder = genuine elevated-risk EXCEPTION that tips risk-benefit toward cholecystectomy. Periampullary umbrella term = reflects genuine diagnostic limitation (4 cancers indistinguishable when advanced), not arbitrary. Gallstone-association split (present in gallbladder CA, ABSENT in bile duct/ampullary CA) = clearest etiologic discriminator despite anatomic proximity — ampullary/bile duct CA tracks with IBD/sclerosing cholangitis/parasites instead.
Tumours of the Biliary Tract
Overview
Biliary tract tumours span rare benign lesions and clinically important malignant ones — carcinoma of the gallbladder, and carcinoma of the ampulla of Vater/extrahepatic bile ducts.
Benign Tumours
Exceedingly rare: papilloma, adenoma, adenomyoma (the commonest of this group), fibroma, lipoma, myxoma, haemangioma. All morphologically resemble their counterparts elsewhere in the body.
Carcinoma of the Gallbladder
The most prevalent cancer of the extrahepatic biliary tract. Like cholelithiasis/cholecystitis, more frequent in women (4:1), peak incidence 7th decade. Often undetected until widely spread and inoperable.
Etiology:
- Cholelithiasis and cholecystitis — the most significant association, though causality is unproven. Present in ~75% of gallbladder cancer cases, but conversely, documented cancer occurs in only ~0.5% of cholelithiasis/cholecystitis patients. Porcelain gallbladder carries a particularly elevated cancer risk.
- Chemical carcinogens structurally similar to natural bile acids — methylcholanthrene, various nitrosamines, pesticides; rubber industry workers show higher incidence.
- Genetic factors — regional clustering suggests a strong genetic component; higher in Japanese immigrants and South-Western Native Americans; lower in American Indians and Mexicans.
- Miscellaneous — prior biliary tract surgery raises subsequent risk; inflammatory bowel disease (UC and Crohn’s) shows higher incidence.
Morphology: commonest site is the fundus, then the neck. Gross — two types: infiltrating (diffuse thickening/induration of the wall, ± deep ulceration invading the wall and liver bed; firm scirrhous cut surface) and fungating (irregular, friable, papillary/cauliflower-like growth into the lumen, wall, and beyond).
Micro:
- Adenocarcinoma (90%) — papillary or infiltrative, well- to poorly-differentiated; mostly non-mucin-secreting, some colloid (mucus-pool-forming).
- Squamous cell carcinoma (~5%) — from squamous metaplastic epithelium.
- Adenosquamous carcinoma — mixed pattern, uncommon.
Clinical features: slow-growing, late symptoms — diagnosis often made incidentally during cholecystectomy for cholelithiasis. Symptomatic disease: pain, jaundice, palpable mass, anorexia, weight loss — usually by this stage the tumour has invaded the liver/adjacent organs and metastasised to regional nodes and distant sites (lung, peritoneum, GI tract).
Carcinoma of the Ampulla of Vater and Extrahepatic Bile Ducts
Ampullary carcinoma (pure form) is adenocarcinoma located at the ampulla of Vater, often demonstrably arising from a pre-existing villous/tubulovillous ampullary adenoma. In advanced disease, it becomes indistinguishable from three neighbouring cancers: adjacent duodenal mucosal cancer with secondary ampullary involvement, terminal bile duct cancer infiltrating the ampulla, or pancreatic head carcinoma merging into the ampulla — hence the umbrella term periampullary carcinoma, covering all four anatomic sites (ampulla of Vater, duodenum, terminal common bile duct, pancreatic head).
Unlike other biliary tract diseases, this cancer is more common in males, peak incidence 6th decade.
Etiology: frequently arises from a pre-existing ampullary polyp, or occurs as part of familial adenomatous polyposis or neurofibromatosis type 1. No association with gallstones (a genuine contrast with gallbladder cancer). Bile duct cancers specifically are associated with ulcerative colitis, sclerosing cholangitis, and parasitic bile duct infestation (Fasciola hepatica, Ascaris lumbricoides, Clonorchis sinensis).
Morphology: ampullary carcinoma may be intra-ampullary (bulging into the duodenum) or periampullary (circumferential growth around the ampulla). Extrahepatic bile duct carcinoma can arise anywhere in the biliary tree, most frequently (descending order): ampulla of Vater, lower common bile duct, hepatic ducts, hepatic duct confluence. Gross: ampullary carcinoma projects into the duodenal lumen with a papillary surface; bile duct carcinoma is usually small (1–2 cm along the duct), producing duct-wall thickening. Micro: adenocarcinoma, well- to poorly-differentiated, ± mucin-secreting; perineural invasion frequently present.
Clinical features: obstructive jaundice (with intense pruritus) is the usual presenting feature; pain, steatorrhoea, weight loss, weakness may accompany. Metastasises to regional lymph nodes. Prognosis is better than pancreatic cancer and bile duct carcinoma specifically.
Clinical Relevance
- Gallbladder cancer’s association-without-causation with cholelithiasis (present in 75% of cancers, but cancer occurs in only 0.5% of stone patients) is a classic statistical-reasoning point — a high association rate in one direction does not imply a meaningfully elevated absolute risk in the other, which is exactly why gallstones alone don’t justify prophylactic cholecystectomy.
- Porcelain gallbladder standing out as a specifically elevated-risk finding (unlike ordinary cholelithiasis) is worth flagging as a genuine indication that tips the risk-benefit calculation toward cholecystectomy.
- The periampullary carcinoma umbrella term is worth understanding as a practical necessity, not an arbitrary grouping — by the time these four cancers are advanced enough to be biopsied/resected, they are histologically and clinically indistinguishable, so the umbrella term reflects a genuine diagnostic limitation.
- The gallstone-association split (present in gallbladder cancer, absent in bile duct/ampullary cancer) is the clearest etiologic discriminator between these two malignancies despite their anatomic proximity — ampullary/bile duct cancer instead tracks with IBD, sclerosing cholangitis, and parasitic infestation.
Tumours of the Biliary Tract
Overview
Biliary tract tumours span rare benign lesions and clinically important malignant ones — carcinoma of the gallbladder, and carcinoma of the ampulla of Vater/extrahepatic bile ducts.
Benign Tumours
Exceedingly rare: papilloma, adenoma, adenomyoma (the commonest of this group), fibroma, lipoma, myxoma, haemangioma. All morphologically resemble their counterparts elsewhere in the body.
Carcinoma of the Gallbladder
The most prevalent cancer of the extrahepatic biliary tract. Like cholelithiasis/cholecystitis, more frequent in women (4:1), peak incidence 7th decade. Often undetected until widely spread and inoperable.
Etiology:
- Cholelithiasis and cholecystitis — the most significant association, though causality is unproven. Present in ~75% of gallbladder cancer cases, but conversely, documented cancer occurs in only ~0.5% of cholelithiasis/cholecystitis patients. Porcelain gallbladder carries a particularly elevated cancer risk.
- Chemical carcinogens structurally similar to natural bile acids — methylcholanthrene, various nitrosamines, pesticides; rubber industry workers show higher incidence.
- Genetic factors — regional clustering suggests a strong genetic component; higher in Japanese immigrants and South-Western Native Americans; lower in American Indians and Mexicans.
- Miscellaneous — prior biliary tract surgery raises subsequent risk; inflammatory bowel disease (UC and Crohn’s) shows higher incidence.
Morphology: commonest site is the fundus, then the neck. Gross — two types: infiltrating (diffuse thickening/induration of the wall, ± deep ulceration invading the wall and liver bed; firm scirrhous cut surface) and fungating (irregular, friable, papillary/cauliflower-like growth into the lumen, wall, and beyond).
Micro:
- Adenocarcinoma (90%) — papillary or infiltrative, well- to poorly-differentiated; mostly non-mucin-secreting, some colloid (mucus-pool-forming).
- Squamous cell carcinoma (~5%) — from squamous metaplastic epithelium.
- Adenosquamous carcinoma — mixed pattern, uncommon.
Clinical features: slow-growing, late symptoms — diagnosis often made incidentally during cholecystectomy for cholelithiasis. Symptomatic disease: pain, jaundice, palpable mass, anorexia, weight loss — usually by this stage the tumour has invaded the liver/adjacent organs and metastasised to regional nodes and distant sites (lung, peritoneum, GI tract).
Carcinoma of the Ampulla of Vater and Extrahepatic Bile Ducts
Ampullary carcinoma (pure form) is adenocarcinoma located at the ampulla of Vater, often demonstrably arising from a pre-existing villous/tubulovillous ampullary adenoma. In advanced disease, it becomes indistinguishable from three neighbouring cancers: adjacent duodenal mucosal cancer with secondary ampullary involvement, terminal bile duct cancer infiltrating the ampulla, or pancreatic head carcinoma merging into the ampulla — hence the umbrella term periampullary carcinoma, covering all four anatomic sites (ampulla of Vater, duodenum, terminal common bile duct, pancreatic head).
Unlike other biliary tract diseases, this cancer is more common in males, peak incidence 6th decade.
Etiology: frequently arises from a pre-existing ampullary polyp, or occurs as part of familial adenomatous polyposis or neurofibromatosis type 1. No association with gallstones (a genuine contrast with gallbladder cancer). Bile duct cancers specifically are associated with ulcerative colitis, sclerosing cholangitis, and parasitic bile duct infestation (Fasciola hepatica, Ascaris lumbricoides, Clonorchis sinensis).
Morphology: ampullary carcinoma may be intra-ampullary (bulging into the duodenum) or periampullary (circumferential growth around the ampulla). Extrahepatic bile duct carcinoma can arise anywhere in the biliary tree, most frequently (descending order): ampulla of Vater, lower common bile duct, hepatic ducts, hepatic duct confluence. Gross: ampullary carcinoma projects into the duodenal lumen with a papillary surface; bile duct carcinoma is usually small (1–2 cm along the duct), producing duct-wall thickening. Micro: adenocarcinoma, well- to poorly-differentiated, ± mucin-secreting; perineural invasion frequently present.
Clinical features: obstructive jaundice (with intense pruritus) is the usual presenting feature; pain, steatorrhoea, weight loss, weakness may accompany. Metastasises to regional lymph nodes. Prognosis is better than pancreatic cancer and bile duct carcinoma specifically.
Clinical Relevance
- Gallbladder cancer’s association-without-causation with cholelithiasis (present in 75% of cancers, but cancer occurs in only 0.5% of stone patients) is a classic statistical-reasoning point — a high association rate in one direction does not imply a meaningfully elevated absolute risk in the other, which is exactly why gallstones alone don’t justify prophylactic cholecystectomy.
- Porcelain gallbladder standing out as a specifically elevated-risk finding (unlike ordinary cholelithiasis) is worth flagging as a genuine indication that tips the risk-benefit calculation toward cholecystectomy.
- The periampullary carcinoma umbrella term is worth understanding as a practical necessity, not an arbitrary grouping — by the time these four cancers are advanced enough to be biopsied/resected, they are histologically and clinically indistinguishable, so the umbrella term reflects a genuine diagnostic limitation.
- The gallstone-association split (present in gallbladder cancer, absent in bile duct/ampullary cancer) is the clearest etiologic discriminator between these two malignancies despite their anatomic proximity — ampullary/bile duct cancer instead tracks with IBD, sclerosing cholangitis, and parasitic infestation.
Tumours of the Biliary Tract
- Frequency map of biliary tract cancer by anatomic site (fundus/neck of gallbladder, ampulla, bile ducts) on a schematic biliary tree
- The four periampullary carcinoma sites (ampulla, duodenum, terminal CBD, pancreatic head) converging at one anatomic point
Tumours of the Biliary Tract
- Frequency map of biliary tract cancer by anatomic site (fundus/neck of gallbladder, ampulla, bile ducts) on a schematic biliary tree
- The four periampullary carcinoma sites (ampulla, duodenum, terminal CBD, pancreatic head) converging at one anatomic point
My Sticky Notes
Personal revision notes, mnemonics and reminders.
